未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (vol 6, pg 528, 2025) 奥德诺奈特单抗单药治疗复发/难治性弥漫性大B细胞淋巴瘤：ELM-2试验第二阶段（vol 6, pg 528, 2025）的主要有效性和安全性分析 Kim, Won Seog; Kim, Tae Min; Cho, Seok-Goo; Jarque, Isidro; Iskierka-Jazdzewska, Elzbieta; Poon, Li Mei; Prince, H. Miles; Zhang, Huilai; Cao, Junning; Zhang, Mingzhi; Tessoulin, Benoit; Oh, Sung Yong; Lim, Francesca; Carpio, Cecilia; Tan, Tran-Der; Ayyappan, Sabarish; Gutierrez, Antonio; Cai, Jingxian; Ufkin, Melanie; Shariff, Saleem; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Walewski, Jan 分享 收藏
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma (vol 35, pg 1039, 2024) 奥德诺克单抗（odronextamab）在复发或难治性滤泡性淋巴瘤患者中的安全性与有效性（卷35，页1039，2024） Kim, T. M.; Taszner, M.; Novelli, S.; Cho, S. -G; Villasboas, J. C.; Merli, M.; Jimenez-Ubieto, A.; Tessoulin, B.; Poon, L. M.; Tucker, D.; Walewski, J.; Yi, S.; Song, Y.; Chong, G.; Bachy, E.; Guidez, S.; Alonso, A.; Jagadeesh, D.; Zhang, W.; Magnano, L.; Iskierka-Jazdzwska, E.; Tani, M.; Shen, B.; Uppala, A.; Zhu, M.; Shariff, S.; Brouwer-Visser, J.; Chaudhry, A.; Mohamed, H.; Ambati, S.; Luminari, S. 分享 收藏
Evaluation of Baseline CAR-Hematotox Scores to Predict Increased Severe Infection Risk in Patients with Relapsed/Refractory Follicular Lymphoma Treated with Odronextamab 评估基线CAR- Hematotox评分对接受奥多奈喹脒治疗复发/难治性滤泡性淋巴瘤患者严重感染风险增加的预测价值 Matasar, Matthew; Tucker, David; Kim, Tae Min; Luminari, Stefano; Cheng, Yuan; Li, Jingjin; Shariff, Saleem; Mohamed, Hesham; Ambati, Srikanth; Chaudhry, Aafia 分享 收藏
Evaluation of CAR-Hematotox Scoring As a Predictor of Infection Risk Following Treatment with Odronextamab (a CD20xCD3 Bispecific Antibody) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma CAR-Hematotox评分作为感染风险预测指标在奥德奈珠单抗（一种CD20xCD3双特异性抗体）治疗复发/难治性弥漫大B细胞淋巴瘤后的评估 Matasar, Matthew; Tucker, David; Kim, Tae Min; Luminari, Stefano; Cheng, Yuan; Li, Jingjin; Shariff, Saleem; Mohamed, Hesham; Ambati, Srikanth; Chaudhry, Aafia 分享 收藏
Treatment Duration and Risk of Fatal Infections in Patients with B-Cell Non-Hodgkin Lymphoma Achieving Complete Response with Odronextamab 奥德诺克单抗（Odronextamab）治疗B细胞非霍奇金淋巴瘤患者完全缓解后，治疗持续时间与致命性感染风险的关系 von Keudell, Gottfried; Hawkes, Eliza A.; Carpio, Cecilia; Topp, Max S.; Shen, Biyi; Li, Jingjin; Hearnden, Claire; Shariff, Saleem; Mohamed, Hesham; Ambati, Srikanth; Chaudhry, Aafia; Ayyappan, Sabarish 分享 收藏
Matching-Adjusted Indirect Comparisons (MAICs) of Odronextamab Versus Mosunetuzumab and Epcoritamab for the Treatment of Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL) after Two or More Lines of Systemic Therapy 奥德诺克单抗与莫斯单特珠单抗和艾普科单特珠单抗治疗经两线或以上系统治疗后复发/难治性滤泡性淋巴瘤(R/R FL)的匹配调整间接比较(MAICs) Jagadeesh, Deepa; Novelli, Silvana; Luminari, Stefano; Taszner, Michal; Merli, Michele; Xu, Yingzxin; Kamat, Siddhesh; Mastikhina, Liza; Ambati, Srikanth; Chen, Jenny; Chan, Keith; Cope, Shannon; Keeping, Sam; Caisip, Clyde; Mohamed, Hesham; Chaudhry, Aafia; Harnett, James; Bisneto, Jose C. Villasboas 分享 收藏
Trial in Progress: Odronextamab for the Treatment of Patients with Relapsed/Refractory Mantle Cell Lymphoma Following Prior BTK Inhibitor Therapy - a Cohort of the ELM-2 Study 进行中试验：奥多奈膦胺（Odronextamab）用于既往接受过BTK抑制剂治疗患者的复发/难治性套细胞淋巴瘤的治疗——ELM-2研究的一个队列 Cho, Seok-Goo; Kim, Tae Min; Taszner, Michal; Chen, Tsai-Yun; Choudhry, Aafia; Ufkin, Melanie; Uppala, Amulya; Sabir, Ayesha; Mohamed, Hesham; Ambati, Srikanth; Bachy, Emmanuel 分享 收藏
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma odronextamab在复发或难治性滤泡性淋巴瘤患者中的安全性和有效性 Kim, T. M.; Taszner, M.; Novelli, S.; Cho, S. -G; Villasboas, J. C.; Merli, M.; Jimenez-Ubieto, A.; Tessoulin, B.; Poon, L. M.; Tucker, D.; Walewski, J.; Yi, S.; Song, Y.; Chong, G.; Bachy, E.; Guidez, S.; Alonso, A.; Jagadeesh, D.; Zhang, W.; Magnano, L.; Iskierka-Jazdzewska, E.; Tani, M.; Shen, B.; Uppala, A.; Zhu, M.; Shariff, S.; Brouwer-Visser, J.; Chaudhry, A.; Mohamed, H.; Ambati, S.; Luminari, S. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Primary analysis of the Phase 2 ELM-2 study: Odronextamab in patients (pts) with relapsed/refractory follicular lymphoma (R/R FL) Chong, Geoffrey; Taszner, Michal; Novelli, Silvana; Cho, Seok-Goo; Villasboas, Jose C.; Ubieto, Ana Jimenez; Tessoulin, Benoit; Poon, Michelle; Tucker, David; Walewski, Jan; Song, Yuqin; Bachy, Emmanuel; Guidez, Stephanie; Alonso, Aranzazu; Jagadeesh, Deepa; Luminari, Stefano; Mayer, Laura Magnano; Iskierka-Jazdzewska, Elzbieta; Tani, Monica; Cai, Jingxian; Uppala, Amulya; Shariff, Saleem; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Kim, Tae Min 分享 收藏
Evolving impact of the COVID-19 pandemic on lung transplant recipients: A single-center experience Sindu, Devika; Razia, Deepika; Bay, Curt; Padiyar, Josna; Grief, Katherine; Buddhdev, Bhuvin; Arjuna, Ashwini; Abdelrazek, Hesham; Mohamed, Hesham; Mcanally, Kendra; Omar, Ashraf; Walia, Rajat; Schaheen, Lara; Tokman, Sofya 分享 收藏
分享 收藏
分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
.png){kind=icon}
分享.png){kind=icon}
收藏